NXTCL (NXTCL) News
Follow NXTCL (NXTCL) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
NextCell Pharma (Q2 review): Just ahead of Phase ll readout
NextCell Pharma (Q2 review): Just ahead of Phase ll readout
EQUITY | Aug 28, 2026, 09:19 AM UTC
L
Nextcell Pharma reports Q2 2026 operating income of SEK 3.0 mln
Nextcell Pharma said Q2 2026 operating income was SEK 3.0 million.
EARNINGS | Aug 27, 2026, 05:33 AM UTC
L
NXTCL reports operating income doubled; first commercial product launched
NXTCL said operating income doubled and it launched its first commercial product, while awaiting pivotal clinical data.
EQUITY | Aug 27, 2026, 05:32 AM UTC